Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
01/2007
01/23/2007US7166586 Sulfonamide lactam inhibitors of FXa and method
01/23/2007CA2334820C Process for the synthesis of carbapenem intermediates, and compounds produced
01/23/2007CA2239968C Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells
01/23/2007CA2191747C (a)-annelated pyrrole derivatives and pharmaceutical use thereof
01/18/2007WO2007008895A1 Kinase inhibitors
01/18/2007WO2007007886A1 An oxime derivative and preparations thereof
01/18/2007WO2007007040A1 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
01/18/2007WO2005070893A3 Azadecalin glucocorticoid receptor modulators
01/18/2007US20070015742 Porphyrin derivatives
01/18/2007US20070015664 2,4,6-Phenyl substituted cyclic ketoenols
01/18/2007CA2602389A1 Kinase inhibitors
01/17/2007EP1480970B1 Quinoline derivatives
01/17/2007CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
01/17/2007CN1896078A Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors
01/16/2007US7164017 Exhibit electrophysiological activity
01/16/2007US7163947 1-Amino 1H-imidazoquinolines
01/16/2007US7163939 important in the progression of many disease states that are induced by the inappropriate proliferation of cells; anticancer agent
01/16/2007CA2254755C Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs
01/16/2007CA2111372C Diaryl 5,6-fusedheterocyclic acids as leukotriene antagonists
01/11/2007WO2007005403A1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands
01/11/2007WO2007004959A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease
01/11/2007WO2007004958A1 Pyridopyrimidine derivatives as pde4 inhibitors for the treatment of inflammatory and' immune diseases
01/11/2007WO2007004688A1 Xanthine oxidase inhibitor
01/11/2007WO2007003506A1 Pyrido-thiazinium dyes
01/11/2007CA2613428A1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands
01/10/2007EP1658294B1 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof
01/10/2007EP1353905B1 Piperidine/piperazine-type inhibitors of p38 kinase
01/10/2007CN1894274A Macrocyclic inhibitors of hepatitis C virus NS3-serine protease
01/10/2007CN1894259A Rifamycin analogs and uses thereof
01/10/2007CN1894258A Compositions useful as inhibitors of protein kinases
01/10/2007CN1894238A Diamine derivatives
01/09/2007US7161010 Methine dyes; coloring compound
01/09/2007US7160900 Tetrahydropyridino or piperidino heterocyclic derivatives
01/09/2007US7160877 Aliphatic nitrogen-containing 5-membered ring compound
01/04/2007WO2007002557A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
01/04/2007US20070004923 Methine compound and silver halide photographic material containing the same
01/04/2007US20070004736 Imidazole derivative, process for producing the same, and use
01/04/2007US20070004714 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
01/04/2007US20070004710 6-({2-[4-(6-Methoxy-[1,5]naphthyridin-4-yl)phenyl]ethylamino}methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one;bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
01/04/2007US20070004709 excitatory amino acid receptors modulators; for the treatment or prevention of disorders of memory and cognition; 6-chloro-4-ethyl-3,4-dihydro-2H-thieno[3,2-e][1,2,4]thiadiazine 1,1-dioxide; anxiety; depression; progressive neurodegenerative diseases
01/04/2007CA2612585A1 Anti-inflammatory aryl nitrile compounds
01/04/2007CA2611552A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
01/03/2007EP1737870A1 Thiazolopyridine derivates, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions
01/03/2007EP1737844A2 Bicyclic anthranilamide derivatives useful as insecticides
01/03/2007EP1737842A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
01/03/2007CN1293070C Quinoline derivatives
01/03/2007CN1293057C Ethylenediamine derivatives
12/2006
12/28/2006WO2006137258A1 Pharmaceutical composition comprising azarhodacyanine compound as active ingredient
12/28/2006WO2006107273A8 Compounds having progestogenic activity and their use
12/28/2006WO2006076568A3 Thiazolopyridines as cannabinoid receptor modulators
12/28/2006US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase
12/27/2006EP1735322A1 Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of type 2 diabetes
12/27/2006EP1735302A1 4-amino-piperidine derivatives as monoamine uptake inhibitors
12/27/2006EP1734951A2 Diphenyl-indol-2-on compounds and their use in the treatment of cancer
12/27/2006EP1597260B1 Triazole compounds useful in therapy
12/27/2006EP1436267B1 Lactam derivatives as antagonists for human 11cby receptors
12/27/2006CN1886407A Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
12/26/2006US7153878 Substituted thiazoles and oxazoles, e.g., 4-{1-[4-[2-(2-Chloro-6-fluoro-phenyl)-ethyl]-2-(4-trifluoromethyl-phenyl)-thiazol-5-yl]-ethylsulfanyl}-2-methyl-phenoxy)-acetic acid; treating atherosclerosis and diabetes and creating Syndrome X
12/26/2006US7153873 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety
12/26/2006US7153850 Lactam compounds and pharmaceutical use thereof
12/21/2006WO2006134378A1 Compounds for the treatment of multi-drug resistant bacterial infections
12/21/2006WO2006118605A3 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents
12/21/2006US20060287374 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/21/2006US20060287355 Imidazo and thiazolopyridines as jak3 kinase inhibitors
12/21/2006US20060287321 Novel Lactam Derivatives
12/21/2006US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction
12/21/2006CA2610900A1 Compounds for the treatment of multi-drug resistant bacterial infections
12/20/2006EP1734040A1 Substituted quinazoline or pyridopyrimidine derivative
12/20/2006EP1732934A1 Novel thiazolopyrazoles and methods of their use
12/20/2006EP1732929A1 Tricyclic benzopyran compound as anti-arrhythmic agents
12/20/2006EP1732928A2 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
12/20/2006EP1732893A2 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
12/20/2006EP1509501B1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
12/20/2006EP1495025B1 Cyclic compounds and the use thereof as light absorbers or light emitters
12/20/2006EP1305308B1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
12/20/2006CN1882565A Novel piperidine-substituted indoles-or hetero-derivatives thereof and their use as modulators of chemokine receptor (CCR-3)
12/20/2006CN1882332A Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
12/19/2006US7151097 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
12/19/2006US7151096 For therapy and prophylaxis of diseases and disorders associated with cyclin-dependent kinases (CDKs) activity
12/14/2006WO2006131185A1 Monomers , oligomers and polymers of thieno (3, 4-d) thiazole
12/14/2006WO2006105291A3 Heterocyclical chromophore architectures with novel electronic acceptor systems
12/14/2006US20060281774 Pyrimidine derivatives for the treatment of abnormal cell growth
12/13/2006EP1731523A1 Thiazolopyrimidine derivative
12/13/2006EP1731505A1 Alkoxyphenylpropanoic acid derivatives
12/13/2006EP1730148A2 Aminobenzoxazoles as therapeutic agents
12/13/2006EP1730145A1 Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
12/13/2006EP1730142A1 Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
12/13/2006EP1730114A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
12/13/2006EP1446127B1 Triazepine derivatives as neurotrophic agents
12/13/2006CN1878779A 2'oxo-voruscharin and derivatives thereof
12/13/2006CN1878778A Process for producing thiazole derivative
12/13/2006CN1878758A Crf antagonists and heterobicyclic compounds
12/13/2006CN1289509C Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, and pharmaceutical compositions containing same
12/13/2006CN1289508C Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, their use and pharmaceutical compositions containing same
12/13/2006CN1289507C Novel insecticidal pyrrole compounds
12/12/2006US7148237 Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
12/12/2006US7148232 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
12/12/2006US7148226 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
12/07/2006WO2006130673A1 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
12/07/2006US20060276490 Thiopyrimidine and isothiazolopyrimidine Kinase Inhibitors
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 152